Clarissa

Inspire Implant for Sleep Apnea: What the Data Shows

Inspire is the first FDA-approved device to treat moderate-to-severe obstructive sleep apnea (OSA) using hypoglossal nerve stimulation, essentially a pacemaker for the tongue, offering a real surgical alternative for people who can’t tolerate CPAP. The success data is genuinely strong: reported success rates around 72 to 75 percent at both one and five years post-implantation,

Inspire Implant for Sleep Apnea: What the Data Shows Read More »

Fibromyalgia and Sleep: The Alpha-Wave Theory, Revisited

  Fibromyalgia and sleep are deeply connected: more than 75 percent of people with fibromyalgia experience non-restorative sleep, and polysomnography studies consistently find real, measurable differences compared to healthy sleepers, less slow-wave sleep, less REM sleep, less total sleep time, and more nighttime arousals and long awakenings. The most famous proposed explanation is a specific

Fibromyalgia and Sleep: The Alpha-Wave Theory, Revisited Read More »

Berberine and Sleep: The Real Science vs. the Marketing

Berberine, nicknamed “nature’s Ozempic,” has become one of the biggest supplement trends of 2025 and 2026, and it does have real, well-documented mechanisms behind its blood-sugar effects: it activates AMPK, a key cellular energy-regulating enzyme, promotes glucose uptake into cells, and inhibits the liver’s glucose production. That part of the story holds up. Even so,

Berberine and Sleep: The Real Science vs. the Marketing Read More »

Cortisol Face: What Doctors Actually Say About It

“Cortisol face,” the TikTok claim that chronically high stress hormone levels cause a rounder, puffier, “swollen” appearance in ordinary stressed-out people, is not a real medical condition. Endocrinologists have been direct about this: Dr. Luma Ghalib, medical director of the Pituitary Center at Ohio State University Wexner Medical Center, states plainly that there’s no real

Cortisol Face: What Doctors Actually Say About It Read More »

Microplastics and Sleep: What’s Real vs. What’s Marketing

Concern about microplastics is legitimate at a general health level: these particles have been genuinely detected in human blood, lungs, placenta, and, in a notable 2024 study, brain tissue. What’s much less established, despite a wave of social media and mattress-marketing content connecting the dots for you, is any direct research linking microplastics specifically to

Microplastics and Sleep: What’s Real vs. What’s Marketing Read More »

Peptides and Sleep: What the FDA Panel Actually Voted On

In July 2026, the FDA’s Pharmacy Compounding Advisory Committee narrowly recommended six experimental peptides, including Epitalon, which is promoted for sleep and longevity, for the 503A Bulks List, a decision that has already generated significant scrutiny. Three things are worth understanding clearly. First, this vote is not FDA approval: it’s a recommendation about whether compounding

Peptides and Sleep: What the FDA Panel Actually Voted On Read More »

CGM and Sleep: What the New Research Actually Shows

Continuous glucose monitors (CGMs) have moved from a diabetes management tool into a mainstream biohacking product, now available over the counter without a prescription (Dexcom’s Stelo, Abbott’s Lingo), often marketed with promises about optimizing sleep through glucose insights. The underlying bidirectional relationship between sleep and blood glucose is real and reasonably well-established, but mostly in

CGM and Sleep: What the New Research Actually Shows Read More »